Methylaminoformyl Chloride

We are Methylaminoformyl Chloride CAS:6452-47-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 6452-47-7
Product Name: Methylaminoformyl Chloride
Other Name:
Methylaminoformyl Chloride
N-methylcarbamoyl chloride
 
Density: 1.2±0.1 g/cm3
Boiling Point: 93ºC (dec.)
Melting Point: 45ºC
Molecular Formula: C2H4ClNO
Molecular Weight: 93.512
Exact Mass: 92.998138
PSA: 29.10000
LogP: 0.28
Index of Refraction: 1.416
 
Specification
Appearance: White crystal
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of 3,4,5-TRIMETHACARB CAS: 2686-99-9.
Intermediates of Tsumacide CAS: 1129-41-5.
Intermediates of Methylthioacetaldoxime CAS: 1053-36-7.
Intermediates of Isoprocarb CAS: 2631-40-5.
Intermediates of Carbofuran CAS: 1563-66-2.
Intermediates of Fenobucarb CAS: 3766-81-2.
Be used as pesticide intermediate, mainly used in the synthesis of the insecticide.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Methylaminoformyl Chloride


Related News: With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.Dimethyl 2-(2-Methoxyphenoxy)Malonate With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.Metiltris (metiletilcetoxima) silano CAS:22984-54-9 In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.126747-14-6 Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).

Related Products
Product Name
tert-butyl N-[(2R)-1-hydroxy-3-phenylmethoxypropan-2-yl]carbamate View Details
ADP View Details
(1S,2R,3S,5R)-3-phenylmethoxy-2-(phenylmethoxymethyl)-6-oxabicyclo[3.1.0]hexane View Details
3-methylthiopropanol manufacturer 2-Amino-4-chlorobenzoic acid manufacturer 1,3,5-Tri-O-Benzoyl-2-Deoxy-2-Fluoro -α-D-Arabinose manufacturer 3-(Trifluoromethoxy)benzonitrile manufacturer Methyl 5-Formyl-2-methoxybenzoate manufacturer